An accurate, sensitive, and specific gas-liquid-chromatographic procedure is described for determining concentrations of thiopental in human plasma. After 
drug assay anesthetics

Thiopental
[5-ethyl-5'-( 1 -methylbutyl) -2-thiobarbituric acidj is an ultra-short-acting barbiturate used to induce anesthesia in man and animals. Numerous methods of analysis for thiopental have been reported in the literature. Most lack the necessary specificity or sensitivity, or both, for completely describing the disposition kinetics of the drug in humans. Oroszlan and Maengwyn-Davies (1) 'reported a nonspecific spectrophotometric assay involving three different wavelengths and having a sensitivity of 1 mg/L. A specific spectrophotofluorometric method (2) has a reported sensitivity of 0.1 mg/L and requires 3 mL of plasma. Several "high-performance" liquid-chromatographic assays for thiopental in plasma have also been reported (3, 4) . The sensitivity of these assays ranges between 0.1 and 1.0 mg/L. Numerous gas-liquid-chromatographic (GLC) procedures for barbiturates other than thiopental have been reported (5-9). A GLC method (10) with use of a flame ionization detector has a reported sensitivity of 0.2 mg/L, but we found it to be nonspecific for thiopental, owing to thepresence of an interfering peak from the methylated oxy analog and metabolite of thiopental (pentobarbital).
A specific and apparently sensitive assay was reported by Van Hamme and Ghoneim (11) to have a "low-end sensitivity" of <25 tg/L and required a 2-mL plasma sample. However, we have not been able to duplicate this analysis at drug concentrations of 25 czgfL. Sennello and Kohn (12), using a nitrogen-sensitive detector, were able to detect concentrations only down to 0.1 mg/L.
These previous studies motivated us to develop an analytical procedure for thiopental that involves off-column derivatization after extraction of a plasma sample, and subsequent quantitation with a selective nitrogen-phosphorus detector.
Peak height ratios are linearly related to thiopental concentrations over the range of 25 tg/L to 10 mg/L. The method is sufficiently accurate, specific, and sensitive to permit thorough characterization of thiopental disposition in humans and animals.
Materials and Methods
Apparatus
We used a gas chromatograph 
Coleman
and Bell, Norwood, OH) was kept refrigerated until used. All aqueous solutions were prepared in glass-redistilled water and stored in glass. Outdated human plasma that had been stored frozen at -20 #{176}C was used in the preparation of the standards after it had thawed to room temperature. 
Internal Standard Solutions
Preparation ofStandardCurves
To 1 mL of plasma containing 0, 25, 50, 100, 250, and 500 ng of thiopental,
we added 1 mL of 1.5 mol/L NaH2PO4, 1 mL of 2-propanol, and 4 mL of hexane (containing 1 mg of phe- The contents of the tube were vortexmixed for 15 s and centrifuged (3000 rpm, 5 mm). The organic (upper) phase was then transferred to a 15-mL test tube containing 1 mL of 2.5 mol/L NaOH. The solution was vortex-mixed for lOs, and centrifuged (3000 rpm, 1 mm), and the hexane layer aspirated.
To the basic aqueous extract was added 4 mL of drug-free hexane and the solution was vortex-mixed, centrifuged, and aspirated as before. To the washed basic aqueous extract we added 1 mL of 3 molfL HCI and 4 mL of hexane. 
Analytical Variables
Reproducibility. The reproducibility of the method was determined from results for repeated injections. Concentrations of 50 and 500 g/L in plasma for the low-end standard curve and 1 and 10 mgfL for the high-end standard curve were prepared and each solution was injected six times into the chromatograph.
Extraction efficiency.
We determined the efficiency of the extraction of thiopental from plasma by adding known amounts of thiopental, equivalent to concentrations of 50 and 500 g/L in plasma, to the hexane layers after extraction of drug-free plasma as previously described.
The concentrations of thiopental in these samples were compared with the same concentrations of thiopental that had been added directly to plasma and extracted as previously described.
Stability.
Concentrations of 50 and 500 ig of thiopental per liter were prepared as described above, each in 10 mL of plasma. One-milliliter or 200-tL samples from each concentration were placed into separate glass tubes and stored at -20 #{176}C. Analyses were performed once a week for eight weeks. On each day of analysis a standard curve in plasma was constructed and the thiopental concentrations of the stored samples were determined by comparing their thiopental/ phenobarbital peak height ratios with those of the standard curve.
Data Analysis
With all standard curves, a straight-line fit of the data was performed by least-squares linear regression analysis. All results are expressed as mean ± standard deviation (SD).
Results and Discussion
The use of a nitrogen-specific detector in analyses for barbiturates has been described by many workers. Such studies show that these compounds are not readily gas-chromatographed without prior derivatization, especially when nano- The CVs for thiopental in plasma for the low-end standard curve were 6.0% (51.7 ± 3.1 tg/L) and 3.9% (507.1 ± 19.8 tg/L), respectively. At the high concentrations, the coefficients of variation for thiopental were 10.5% (1.05 ± 0.11 mg/L) and 3.4% (10.14 ± 0.34 mg/L), respectively.
Analytical recovery of thiopental from plasma averaged 89.9
(SD 6.6)% and 82.8 (SD 2.2)% at 50 and 500 sg/L, respectively.
No detectable deterioration in thiopental was observed over an eight-week study period. The 50 and 500 g/L solutions yielded concentrations of 49.9 (SD 4.6) tg/L and 497.5 (SD 29.2) zg/L, respectively. Diazepam, fentanyl, and morphine-drugs frequently used in conjunction with thiopental-were tested for potential interference with the thiopental assay. These drugs are bases and are not extracted in our procedure, so, as expected, we saw no interfering peaks at the retention times of thiopental or its internal standard, phenobarbital. Our method is more sensitive and specific than other published methods. The 25 tg/L sensitivity of the assay described here is necessary to characterize completelythe pharmacokinetics of thiopental after the usual 3-4 mg/kg induction doses. An illustration of the latter application is shown in Figure 2 , a plot of thiopental serum concentrations as a function of time after the intravenous administration of a 4.8 mg/kg dose of thiopental sodium to one subject. The assay sensitivity permitted characterization of the concentrationtime course for two days; the data were best described by a triexponential function with a terminal elimination half-life of 8.6 h.
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